Associate Professor Mate Vamos

Associate Professor Mate Vamos

University of Szeged, Szeged (Hungary)

Member of:

Dr. Mate Vamos, PhD, med. habil. is a consultant cardiologist/electrophysiologist at the Cardiology Center of the University of Szeged, Hungary. As an associate professor, he is the head of the pacing&ICD program at the Cardiac Electrophysiology Division. He is a member of the European Heart Rhythm Association (EHRA) and member/vice-president of the Working Group on Cardiac Arrhythmias and Pacing of the Hungarian Society of Cardiology. He performs all types of CIED implantations (including S-ICDs, leadless pacemakers and conduction system pacing), involved in lead extraction program, and active in invasive electrophysiology procedures. Dr. Vamos is also an EHRA Certified Cardiac Device Specialist (level 1-2) and an EHRA Certified Invasive Cardiac Electrophysiologist (level 1-2).

Presentations Articles

Key influences of VDD (DX) ICD selection: results from a prospective, national survey

Event: EHRA 2024

Topic: Cardioversion and Defibrillation

Session: Poster session on devices, others

Access

A head-to-head comparison of the first choice and crossover lead extraction tool: laser vs. mechanical

Event: EHRA 2022

Topic: Device Complications and Lead Extraction

Session: Moderated ePosters - Remote monitoring and device complications

Access

Dronedarone vs placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial

Event: ESC Congress 2020

Topic: Antiarrhythmic Drug Treatment

Session: Arrhythmias, General ePosters

Access

Impact of ablation status on the efficacy and safety of dronedarone in patients with atrial fibrillation/flutter: a post-hoc analysis of the ATHENA trial

Event: ESC Congress 2019

Topic: Treatment

Session: Atrial fibrillation ablation and outcomes

Access

Accumulating evidence for deleterious effects of digoxin in heart failure and atrial fibrillation: an updated meta-analysis

Event: ESC Congress 2018

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic heart failure – Pathophysiology and mechanisms

Access

Effects of upgrade versus de-novo cardiac resynchronization therapy on clinical response and long-term survival: Results form a large multicenter study

Event: ESC Congress 2016

Topic: Resynchronisation therapy

Session: Clinical results in CRT: patient groups, leads and optimisation

Access

Associate Professor Mate Vamos

Biography

Contributor content

Key influences of VDD (DX) ICD selection: results from a prospective, national survey

A head-to-head comparison of the first choice and crossover lead extraction tool: laser vs. mechanical

Dronedarone vs placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial

Impact of ablation status on the efficacy and safety of dronedarone in patients with atrial fibrillation/flutter: a post-hoc analysis of the ATHENA trial

Accumulating evidence for deleterious effects of digoxin in heart failure and atrial fibrillation: an updated meta-analysis

Effects of upgrade versus de-novo cardiac resynchronization therapy on clinical response and long-term survival: Results form a large multicenter study

ESC 365 is supported by